Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focus
By Deena BeasleySAN FRANCISCO, Nov 29 (Reuters) - An experimental Alzheimer's disease drug from Eisai and Biogen slowed cognitive decline in a...
By Deena BeasleySAN FRANCISCO, Nov 29 (Reuters) - An experimental Alzheimer's disease drug from Eisai and Biogen slowed cognitive decline in a...